HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by LIPSCOMB, G. H. Articles by LING, F. W. Search for Related Content PubMed PubMed Citation Articles by LIPSCOMB, G. H. Articles by LING, F. W.

Management of Separation Pain After Single-Dose Methotrexate Therapy for Ectopic Pregnancy

From the Department of Obstetrics and Gynecology, University of Tennessee, Memphis, Memphis, Tennessee.

Address reprint requests to: Gary H. Lipscomb, MD, Department of Obstetrics and Gynecology, University of Tennessee, Room E-102, 853 Jefferson Avenue, Memphis, TN 38163, E-mail: glipscomb{at}utmem1.utmem.edu

Objective: To evaluate the conservative management of pain after systemic methotrexate therapy for ectopic pregnancy; identify prognostic factors for success; and compare hCG resolution time for patients with and without pain.

Methods: A retrospective review of patients with ectopic pregnancy requiring evaluation for pain after receiving single-dose methotrexate therapy is performed. Results of hematocrits, ultrasound findings, hCG levels, time for hCG levels to reach less than 15 mIU/mL, and outcome were noted.

Results: Fifty-three patients with 64 episodes of pain were identified. Seven hospitalized patients required surgery during admission. Two previously hospitalized and one outpatient also ultimately underwent surgery. For hospitalized patients, there were no statistical differences between patients who did or did not undergo surgery during admission for any variable studied, including the presence of free peritoneal blood or rebound tenderness. However, comparison of hospitalized and nonhospitalized patients showed those with rebound tenderness were more likely to be admitted. Hospitalized patients not requiring surgery had shorter resolution time than nonhospitalized patients. For hospitalized and nonhospitalized patients, the median time from treatment to presentation for pain was 8 days.

Conclusion: The occurrence of pain following methotrexate therapy for ectopic pregnancy should not be the sole indication for surgical intervention. The majority of stable patients with pain after methotrexate therapy, even with rebound or free peritoneal fluid, can be treated successfully without surgery, either in hospital with close observation for severe pain or as outpatients for patients with less severe pain.

This article has been cited by other articles:

				B. E. Seeber and K. T. Barnhart Suspected Ectopic Pregnancy Obstet. Gynecol., February 1, 2006; 107(2): 399 - 413. [Abstract] [Full Text] [PDF]

				G. H. Lipscomb, T. G. Stovall, and F. W. Ling Nonsurgical Treatment of Ectopic Pregnancy N. Engl. J. Med., November 2, 2000; 343(18): 1325 - 1329. [Full Text] [PDF]